Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Starting semaglutide at 0.5 mg is the typical initiation dose recommended in clinical practice for weight management, though some patients respond differently based on their genetic profile and metabolic factors. PlexusDx provides access to compounded semaglutide injection starting at $149 per month, with dosing adjustments tailored to your individual needs—without pricing changes as your dose increases.

What Is the Standard Semaglutide Starting Dose?

The 0.5 mg injection represents the widely accepted entry point for semaglutide weight loss therapy, established through clinical trials and real-world medical practice. This dose is intended as a gentle introduction to help your body adjust to the medication while minimizing gastrointestinal side effects. Most treatment protocols advance from 0.5 mg upward over 4 to 12 weeks based on tolerance and weight loss response, with final therapeutic doses ranging from 1.0 mg to 2.4 mg.

Beginning at a lower threshold like 0.5 mg allows your healthcare provider to monitor how your body responds before moving to higher amounts. This titration approach reduces nausea and helps you develop confidence in the medication. Your doctor may recommend staying at 0.5 mg for one to two weeks before increasing, depending on your side effect profile and appetite suppression.

Is 0.5 mg Enough for Weight Loss Results?

A 0.5 mg dose may produce noticeable appetite reduction and modest weight loss in some people, particularly those with mild to moderate obesity or insulin resistance. However, research shows that maximum weight loss typically occurs at higher maintenance doses—usually 1.7 mg to 2.4 mg—where the medication's full GLP-1 receptor activation takes effect. Starting at 0.5 mg is rarely the final dose; it is a stepping stone designed for tolerability, not optimal therapeutic effect.

Individual genetics play a significant role in how much benefit you experience at any given dose. Some patients metabolize semaglutide quickly and may need faster dose escalation, while others achieve substantial results at lower levels. The Precision Peptide Genetic Test from PlexusDx analyzes your GLP1R gene variant and 13 other peptide pathways to predict your likely response pattern, helping your provider choose the best starting and target doses for your unique biology.

How Does Dose Escalation Work in Semaglutide Therapy?

Dose escalation typically follows a weekly or biweekly schedule, with increases of 0.25 mg or 0.5 mg every 1 to 2 weeks until you reach your target maintenance dose. A common progression looks like 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg over 8 to 16 weeks, though your provider may adjust timing based on your individual response. Faster escalation increases side effect risk, while slower escalation may delay weight loss benefits.

PlexusDx providers work with you to find the right escalation rhythm for your body and lifestyle. Your dose may need to go up. Your price won't—all compounded semaglutide remains priced flat at $149 per month across all commitment tiers, regardless of whether you're at 0.5 mg or 2.4 mg. This transparent pricing model removes the financial barrier to reaching your optimal therapeutic dose.

Why Choose PlexusDx for Your Semaglutide Treatment?

PlexusDx partners with licensed 503A compounding pharmacies to deliver affordable, personalized semaglutide injections to all 50 states without insurance requirements or membership fees. Your treatment includes access to trained clinical staff who adjust your protocol based on your response, side effects, and weight loss milestones. HSA and FSA accounts are eligible, making treatment more financially accessible.

The optional Precision Peptide Genetic Test ($99 after your first month) reveals your genetic predispositions in GLP-1 signaling, insulin metabolism, and appetite regulation pathways. This data helps your provider predict whether you'll respond well at lower doses or need faster escalation, optimizing your journey from the start. Combined with regular check-ins and dose adjustments, PlexusDx removes guesswork from semaglutide therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 0.5 mg semaglutide enough to lose weight?

Many patients experience appetite reduction and initial weight loss at 0.5 mg, but maximum weight loss typically occurs at higher maintenance doses of 1.7–2.4 mg. The 0.5 mg starting dose is designed for tolerability, not optimal therapeutic effect—it's a stepping stone toward your target dose. PlexusDx providers adjust your dose based on your individual response and goals.

How quickly should my semaglutide dose increase?

Standard escalation adds 0.25–0.5 mg weekly or biweekly until you reach your target dose, typically over 8–16 weeks. Faster escalation increases nausea and GI side effects, while slower escalation delays benefits. Your PlexusDx provider customizes your escalation schedule based on your tolerance and progress.

Will my PlexusDx cost increase if my semaglutide dose goes higher?

No. PlexusDx compounded semaglutide injection is priced flat at $149 per month across all commitment tiers, regardless of your dose level. Your dose may need to go up. Your price won't. This transparent model ensures you can safely reach your optimal therapeutic dose without financial barriers.

What side effects should I expect at 0.5 mg?

Common early side effects include mild nausea, decreased appetite, and occasional constipation or fatigue. Most side effects are temporary and improve as your body adjusts within 1–2 weeks. If side effects are severe or persistent, your PlexusDx provider may slow your dose escalation or adjust timing to improve tolerability.

Can the Precision Peptide Genetic Test predict if 0.5 mg will work for me?

The Precision Peptide Genetic Test analyzes your GLP1R gene variant and 13 other peptide pathways (including FTO, MC4R, and GIPR) to predict your metabolic response pattern. This data helps your provider determine whether you'll benefit from standard escalation or may need faster dose advancement for optimal results. The test costs $99 after your first month of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves